Answers are grounded in this paper and cite their sources.
Demonstrates 68Ga-NODAGA-exendin-4 PET detection of GLP-1 receptor expression in atherosclerotic mice, indicating its potential for tracking vascular inflammation.
Cardiovascular effects of glucagon-like peptide-1 receptor (GLP-1R) agonist therapies are potentially mediated by anti-inflammatory effects on atherosclerosis. Our study demonstrates that 68Ga-NODAGA-exendin-4, a radioligand specifically targeting GLP-1R, detects GLP-1R expression in inflamed atherosclerotic lesions in nondiabetic and diabetic hypercholesterolemic mice. Immunofluorescence staining suggests that GLP-1R is primarily localized in M2 macrophages in lesions. This study describes a new potential tool that may have translational relevance for studies of pharmacological modification of GLP-1R signaling in atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Ståhle et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: